SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-24-063386
Filing Date
2024-03-08
Accepted
2024-03-08 13:34:49
Documents
1
Effectiveness Date
2024-03-08

Document Format Files

Seq Description Document Type Size
1 S-8 POS d767293ds8pos.htm S-8 POS 26857
  Complete submission text file 0001193125-24-063386.txt   27990
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Filer) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-271966-01 | Film No.: 24733517
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)